Passa al contenuto
Merck

In-vitro engineered human cerebral tissues mimic pathological circuit disturbances in 3D.

Communications biology (2022-03-25)
Aref Saberi, Albert P Aldenkamp, Nicholas A Kurniawan, Carlijn V C Bouten
ABSTRACT

In-vitro modeling of brain network disorders such as epilepsy remains a major challenge. A critical step is to develop an experimental approach that enables recapitulation of in-vivo-like three-dimensional functional complexity while allowing local modulation of the neuronal networks. Here, by promoting matrix-supported active cell reaggregation, we engineered multiregional cerebral tissues with intact 3D neuronal networks and functional interconnectivity characteristic of brain networks. Furthermore, using a multi-chambered tissue-culture chip, we show that our separated but interconnected cerebral tissues can mimic neuropathological signatures such as the propagation of epileptiform discharges.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
CHIR99021, ≥98% (HPLC)
Sigma-Aldrich
Monoclonale Anti-proteina acida gliale fibrillare (GFAP), clone G-A-5, ascites fluid
Sigma-Aldrich
Anticorpo anti-tubulina, isoforma beta III, porzione C-terminale, clone TU-20 (simile a TUJ1), ascites fluid, clone TU-20 (Similar to TUJ1), Chemicon®
Sigma-Aldrich
Anticorpo anti-trasportatore vescicolare del GABA (VGAT), Chemicon®, from rabbit
Sigma-Aldrich
Anti-OLIG2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Monoclonal Anti-VGLUT1 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL2754, purified immunoglobulin, buffered aqueous glycerol solution